Rating Change
Cantor Fitzgerald reiterated its Overweight rating on NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) on November 11, 2026.
Cantor Fitzgerald reiterated its Overweight rating on NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) on November 11, 2026.

At publication ·
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) · reiterate
At a glance
Cantor Fitzgerald reiterated its Overweight rating on NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) on November 11, 2026.
NewAmsterdam Pharma Company N.V. operates in the Healthcare sector. The stock currently trades at $20.02 with a market capitalization of $4.1B.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for NewAmsterdam Pharma Company N.V.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 11, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Nov 05, 2026 | Needham | Buy | N/A |
| Oct 05, 2026 | RBC Capital | Outperform | N/A |
| Sep 08, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 06, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View NAMS Stock Page
A rating of Overweight from Cantor Fitzgerald reflects the analyst's outlook on NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NAMS forecast page.
Keep reading
earnings ·
sec_filing ·
sec_filing ·
price ·
Current market data
NASDAQ · NAMS
$18.41
Down: -$1.10 · -5.64%
Live quote updated